Discovery of new antiviral agents through artificial intelligence: in vitro and in vivo results
arXiv:2611.22230v1 Announce Type: new Abstract: In this research, we employed a deep reinforcement learning (RL)-based molecule design platform to generate a diverse set of compounds targeting the neuraminidase (NA) of influenza A and B viruses.